Search alternatives:
great therapeutic » a therapeutic (Expand Search)
decrease » increase (Expand Search)
Showing 1 - 7 results of 7 for search '(( decrease therapeutic options ) OR ( great therapeutic options ))*', query time: 0.06s Refine Results
  1. 1
    Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells

    Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells by Nihal AlMuraikhi (6002234)

    Published 2019
    “…We identified γ-secretase inhibitor (LY411575) as a potent regulator of osteoblastic differentiation of hBMSC that may be useful as a therapeutic option for treating conditions associated with ectopic bone formation.…”
    Save to List
    Saved in:
  2. 2
    Efficacy And Safety of Cannabidiol on Juvenile Diabetes Outcomes in Male Rats

    Efficacy And Safety of Cannabidiol on Juvenile Diabetes Outcomes in Male Rats by Awkar, Nai

    Published 2023
    Get full text
    Get full text
    Get full text
    masterThesis
    Save to List
    Saved in:
  3. 3
    Arginine Deprivation in AML Cells Induces Ferroptosis, a Type of Autophagy-Mediated Cell Death

    Arginine Deprivation in AML Cells Induces Ferroptosis, a Type of Autophagy-Mediated Cell Death by Tohme, Sara

    Published 2023
    Get full text
    Get full text
    Get full text
    masterThesis
    Save to List
    Saved in:
  4. 4
    Bone-targeted therapies in metastatic castration-resistant prostate cancer

    Bone-targeted therapies in metastatic castration-resistant prostate cancer by El-Amm, Joelle

    Published 2013
    “…Other novel bone-targeted agents are currently in development, including the receptor tyrosine kinase inhibitors cabozantinib and dasatinib. Emerging therapeutics in mCRPC has resulted in great strides in preventing one of the most significant sources of complications of bone metastases.…”
    Get full text
    Get full text
    Get full text
    Get full text
    article
    Save to List
    Saved in:
  5. 5
    Comprehensive Transcriptome and Pathway Analyses Revealed Central Role for Fascin in Promoting Triple-Negative Breast Cancer Progression

    Comprehensive Transcriptome and Pathway Analyses Revealed Central Role for Fascin in Promoting Triple-Negative Breast Cancer Progression by Rayanah Barnawi (8737584)

    Published 2021
    “…However, cancer-related death remains high especially in triple-negative breast cancer (TNBC) due limited therapeutic options. Development of targeted therapies for TNBC requires better understanding of biology and signaling networks that promote disease progression. …”
    Save to List
    Saved in:
  6. 6
    1787 evaluation of transperineal prostatic administration of a PSA-activasted protoxin (PRX302) in men with luts secondary to BPH

    1787 evaluation of transperineal prostatic administration of a PSA-activasted protoxin (PRX302) in men with luts secondary to BPH by Elhilali, Mostafa

    Published 2010
    “…PRX302 could offer an interesting therapeutic option for patients with LUTS 2ry to BPH.…”
    Get full text
    Get full text
    Get full text
    Get full text
    article
    Save to List
    Saved in:
  7. 7
    Hedgehog Signaling Inhibition by Smoothened Antagonist BMS-833923 Reduces Osteoblast Differentiation and Ectopic Bone Formation of Human Skeletal (Mesenchymal) Stem Cells

    Hedgehog Signaling Inhibition by Smoothened Antagonist BMS-833923 Reduces Osteoblast Differentiation and Ectopic Bone Formation of Human Skeletal (Mesenchymal) Stem Cells by Nihal AlMuraikhi (6002234)

    Published 2019
    “…We identified SMO/Hedgehog antagonist (BMS-833923) as a powerful inhibitor of osteoblastic differentiation of hMSC that may be useful as a therapeutic option for treating conditions associated with high heterotopic bone formation and mineralization.…”
    Save to List
    Saved in:

Search Tools: